Geoffrey Hackett

3.4k total citations
75 papers, 2.4k citations indexed

About

Geoffrey Hackett is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, Geoffrey Hackett has authored 75 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Endocrinology, Diabetes and Metabolism, 40 papers in Pharmacology and 37 papers in Psychiatry and Mental health. Recurrent topics in Geoffrey Hackett's work include Hormonal and reproductive studies (58 papers), Pharmacology and Obesity Treatment (39 papers) and Sexual function and dysfunction studies (36 papers). Geoffrey Hackett is often cited by papers focused on Hormonal and reproductive studies (58 papers), Pharmacology and Obesity Treatment (39 papers) and Sexual function and dysfunction studies (36 papers). Geoffrey Hackett collaborates with scholars based in United Kingdom, United States and Italy. Geoffrey Hackett's co-authors include Kate M. Dunn, Peter Croft, Nigel Cole, Sudarshan Ramachandran, David O. Kennedy, Richard C. Strange, Mithun Bhartia, Jessie Raju, Peter Wilkinson and Richard Sadovsky and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Reviews Disease Primers and Mayo Clinic Proceedings.

In The Last Decade

Geoffrey Hackett

68 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geoffrey Hackett United Kingdom 28 1.6k 1.2k 683 424 370 75 2.4k
Elisa Maseroli Italy 26 1.3k 0.8× 814 0.7× 385 0.6× 356 0.8× 254 0.7× 76 2.2k
Luiz Otávio Torres Brazil 18 1.2k 0.8× 1.6k 1.4× 307 0.4× 368 0.9× 698 1.9× 28 2.4k
Ignacio Moncada Spain 28 1.5k 0.9× 2.0k 1.7× 438 0.6× 332 0.8× 472 1.3× 92 2.9k
Alessandra Sforza Italy 38 3.5k 2.2× 1.8k 1.5× 1.1k 1.7× 955 2.3× 404 1.1× 104 4.7k
Amy B. O’Donnell United States 21 2.4k 1.4× 618 0.5× 809 1.2× 749 1.8× 135 0.4× 26 3.0k
Andrew McCullough United States 28 1.2k 0.8× 1.8k 1.5× 238 0.3× 353 0.8× 405 1.1× 81 2.6k
Antonio Martín‐Morales Spain 20 1.3k 0.8× 1.7k 1.4× 183 0.3× 197 0.5× 599 1.6× 39 2.1k
Rany Shamloul Egypt 29 829 0.5× 1.6k 1.3× 152 0.2× 287 0.7× 521 1.4× 77 2.3k
Jae‐Seung Paick South Korea 37 1.2k 0.7× 1.6k 1.4× 218 0.3× 413 1.0× 354 1.0× 217 4.2k
Hartmut Porst United States 33 2.1k 1.3× 3.2k 2.7× 286 0.4× 349 0.8× 1.2k 3.2× 85 4.0k

Countries citing papers authored by Geoffrey Hackett

Since Specialization
Citations

This map shows the geographic impact of Geoffrey Hackett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey Hackett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey Hackett more than expected).

Fields of papers citing papers by Geoffrey Hackett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoffrey Hackett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey Hackett. The network helps show where Geoffrey Hackett may publish in the future.

Co-authorship network of co-authors of Geoffrey Hackett

This figure shows the co-authorship network connecting the top 25 collaborators of Geoffrey Hackett. A scholar is included among the top collaborators of Geoffrey Hackett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoffrey Hackett. Geoffrey Hackett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hackett, Geoffrey. (2024). Long Term Cardiovascular Safety of Testosterone Therapy: A Review of the TRAVERSE Study. The World Journal of Men s Health. 43(2). 282–282. 3 indexed citations
3.
Hackett, Geoffrey, Ahmad Haider, Karim Sultan Haider, et al.. (2024). Testosterone Replacement Therapy: Effects on Blood Pressure in Hypogonadal Men. The World Journal of Men s Health. 42(4). 749–749. 4 indexed citations
4.
Strange, Richard C., et al.. (2024). Adult-onset testosterone deficiency: the usefulness of hormone replacement in reducing mortality in men with this common age-related condition. SHILAP Revista de lepidopterología. 1(3). 83–99. 3 indexed citations
5.
Strange, Richard C., Geoffrey Hackett, Ahmad Haider, et al.. (2023). Testosterone replacement therapy: association with mortality in high‐risk patient subgroups. Andrology. 12(6). 1389–1397.
6.
Hackett, Geoffrey. (2020). Should All Men with Type 2 Diabetes Be Routinely Prescribed a Phosphodiesterase Type 5 Inhibitor?. The World Journal of Men s Health. 38(3). 271–271. 12 indexed citations
7.
Hackett, Geoffrey & Michael Kirby. (2020). COVID-19, Type 2 Diabetes, and Hypogonadism: Lessons for Acute Management and Long-Term Prevention. 1(1). 22–31. 4 indexed citations
8.
Hackett, Geoffrey & Michael Kirby. (2020). Testosterone deficiency in men infected with COVID‐19. Trends in Urology & Men s Health. 11(6). 7–10. 5 indexed citations
9.
Kirby, Michael, et al.. (2020). New testosterone 2% gel using Ferring Advanced Skin Technology (FAST), for the treatment of testosterone deficiency in men, with a novel applicator. Expert Review of Endocrinology & Metabolism. 15(4). 217–226. 1 indexed citations
10.
Hackett, Geoffrey. (2019). Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic Syndrome. Sexual Medicine Reviews. 7(3). 476–490. 27 indexed citations
11.
Ramachandran, Sudarshan, Richard C. Strange, Anthony A. Fryer, Farid Saad, & Geoffrey Hackett. (2018). The association of sex hormone‐binding globulin with mortality is mediated by age and testosterone in men with type 2 diabetes. Andrology. 6(6). 846–853. 11 indexed citations
12.
Hackett, Geoffrey, Michael Kirby, David F. Edwards, et al.. (2017). UK policy statements on testosterone deficiency. International Journal of Clinical Practice. 71(3-4). e12901–e12901. 14 indexed citations
13.
14.
Debruyne, F.M.J., Hermann M. Behre, Claus G. Roehrborn, et al.. (2016). Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men. British Journal of Urology. 119(2). 216–224. 59 indexed citations
15.
Morgentaler, Abraham, Michael Zitzmann, Abdulmaged M. Traish, et al.. (2016). Fundamental Concepts Regarding Testosterone Deficiency and Treatment. Mayo Clinic Proceedings. 91(7). 881–896. 82 indexed citations
16.
Corona, Giovanni, Elisa Maseroli, Giulia Rastrelli, et al.. (2016). Is late-onset hypogonadotropic hypogonadism a specific age-dependent disease, or merely an epiphenomenon caused by accumulating disease-burden?. PubMed. 41(2). 196–210. 37 indexed citations
17.
Hackett, Geoffrey. (2015). An update on the role of testosterone replacement therapy in the management of hypogonadism. Therapeutic Advances in Urology. 8(2). 147–160. 16 indexed citations
18.
Price, David E. & Geoffrey Hackett. (2008). Management of erectile dysfunction in diabetes: An update for 2008. Current Diabetes Reports. 8(6). 437–443. 8 indexed citations
19.
Hackett, Geoffrey, et al.. (1993). Management of joint and soft tissue injuries in three general practices: value of on-site physiotherapy.. PubMed. 43(367). 61–4. 46 indexed citations
20.
Hackett, Geoffrey, et al.. (1987). Evaluation of the efficacy and acceptability to patients of a physiotherapist working in a health centre.. BMJ. 294(6563). 24–26. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisa Maseroli Breakdown of academic impact, for papers by Luiz Otávio Torres Breakdown of academic impact, for papers by Ignacio Moncada Breakdown of academic impact, for papers by Alessandra Sforza Breakdown of academic impact, for papers by Amy B. O’Donnell Breakdown of academic impact, for papers by Andrew McCullough Breakdown of academic impact, for papers by Antonio Martín‐Morales Breakdown of academic impact, for papers by Rany Shamloul Breakdown of academic impact, for papers by Jae‐Seung Paick Breakdown of academic impact, for papers by Hartmut Porst
Rankless by CCL
2026